We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Providing convenient and affordable healthcare to patients either at home or their workplace. Practitioners can visit patients and offer a range of medical treatments including vaccinations, testing, physiotherapy and primary care. Qured have been highly successful in London and are growing at an alarming rate, ready to help the whole of the UK.
days to go: Expired investment: £763,160
Doctors available 24 hours a day, 365 days a year to visit, diagnose, treat, refer and prescribe medication as needed. No membership fees or hidden costs.
days to go: Expired investment: £540,695
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go: Expired investment: £76,030
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £532,311
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
Ultramed are a health tech company, placing patient experience and innovation at the forefront. They operate a suite of cloud based pre operative products by combining clinical NHS operative experience. The aim is to reduce costs increase health care resources.
days to go: Expired investment: £317,540
During their stay in hospital, around 7-10% of patients attract unexpected infections. In some cases, this is caused by unclean complex surgical tools. Aspetium have developed ultrasonic washers (dubbed "uSonic") to thoroughly decontaminate expensive surgical instruments, which can be safely reused to potentially prevent easily avoidable infections.
days to go: Expired investment: £151,167
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £691,497
FloatWind manufactures mass-produced floating offshore wind turbines. It seeks to disrupt the £20 billion offshore wind energy market. The company argues that conventional offshore wind farms, installed at sea, use expensive and slow installation methods that are also dangerous to the marine environment. It further stresses that the high cost of installation is often borne by the consumer. FloatWind asserts that its business model is different. The company claims to build its products on land and then floats its ready-to-float turbines out to sea. The company points out that this reduces environmental damage, substantially reduces costs, and makes offshore wind energy cheaper. FloatWind was selected for a 6-month UK Innovate Edge business mentoring programme and appeared for SetSquared Business Mentoring Seminar in May 2021. The company has 3,000+ followers on LinkedIn. FloatWind states it will use the investment for product development, expanding its team, IP protection, promoting marketing and PR, and boosting its manufacturing capabilities.
days to go: Expired investment: £311,497
Advanced Blast & Ballistic Systems (ABBS) develops patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. ABBS asserts that mines and IEDs accounted for over 80% of UK and US army casualties in Iraq and Afghanistan. ABBS argues that its systems can reverse this scenario. It aspires to become a contender in the $20 billion armoured vehicle protection market. The company has been tasked by the European Union Aviation Safety Agency (EASA) and European Organisation for Civil Aviation Equipment (EUROCAE) to draft safety regulations for emergency descent arrest systems. It also holds multiple patents for its proven Vehicle Global Acceleration Mitigation (VGAM) vehicle mine protection system and has a patent pending for a Zero-Zero Crash Prevention (ZZCP) system for light aircraft and electric Vertical Takeoff and Landing (eVTOLs) systems. ABBS will use the investment for marketing, boosting R&D, and maintaining and expanding its IP/patent portfolio.
days to go: Expired investment: £297,534
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph